Is Vertex Pharmaceuticals Incorporated (VRTX) a Buy, Sell, or Hold?
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$474.52 USD
-$1.79 (-0.38%)
- Volume
- 10.9K
- Average Volume
- 1.49M
- Market Capitalization
- $120.44B
- P/E Ratio
- 27.90
- Dividend Yield
- 0.00%
- Price Target
- $572.00
- Year High
- $533.67
- Year Low
- $362.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.02
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.73%
Investors Holding
148
change: -1603 | last: 1751
Increased Positions
71
change: -764 | last: 835
Reduced Positions
42
change: -556 | last: 598
New Positions
17
change: -134 | last: 151
Sold Positions
1565
change: 1432 | last: 133
Total Calls
-
Total Puts
800
Put-Call Ratio
0.00
change: -78.473 | last: 0.7847
Total Invested
901.93M
VRTX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $453.36 | 255.7M | $115.92B | $5.09B | $3.88B | $114.72B |
| 2024-12-31 | $402.70 | 257.5M | $103.7B | $4.57B | $1.75B | $100.88B |
| 2023-12-31 | $406.89 | 257.7M | $104.86B | $10.37B | $808.4M | $95.29B |
| 2022-12-31 | $288.78 | 256.1M | $73.96B | $10.5B | $899.7M | $64.35B |
| 2021-12-31 | $219.60 | 257.7M | $56.59B | $6.8B | $967.4M | $50.76B |
| 2020-12-31 | $236.34 | 259.84M | $61.41B | $5.99B | $931.9M | $56.35B |
| 2019-12-31 | $218.95 | 256.73M | $56.21B | $3.11B | $661.66M | $53.76B |
| 2018-12-31 | $165.71 | 254.29M | $42.14B | $2.65B | $586.82M | $40.08B |
| 2017-12-31 | $149.86 | 248.86M | $37.29B | $1.67B | $606.43M | $36.23B |
| 2016-12-31 | $73.67 | 243.59M | $17.95B | $1.18B | $840.76M | $17.6B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $446.54 | 254.1M | $113.47B | $5.49B | $1.99B | $109.96B |
| 2025-12-31 | $453.36 | 253.9M | $115.11B | $5.09B | $3.88B | $113.9B |
| 2025-09-30 | $391.64 | 255.6M | $100.1B | $4.94B | $1.83B | $97B |
| 2025-06-30 | $445.20 | 256.7M | $114.28B | $4.97B | $1.53B | $110.84B |
| 2025-03-31 | $484.82 | 256.9M | $124.55B | $4.67B | $1.65B | $121.52B |
| 2024-12-31 | $402.70 | 257.5M | $103.7B | $4.57B | $1.75B | $100.88B |
| 2024-09-30 | $465.08 | 258M | $119.99B | $5.24B | $1.7B | $116.45B |
| 2024-06-30 | $471.25 | 258.1M | $121.63B | $4.58B | $933.4M | $117.98B |
| 2024-03-31 | $420.48 | 258.2M | $108.57B | $9.16B | $721.3M | $100.13B |
| 2023-12-31 | $406.89 | 257.7M | $104.86B | $10.37B | $808.4M | $95.29B |
| 2023-09-30 | $347.74 | 258M | $89.72B | $11.11B | $744.7M | $79.35B |
| 2023-06-30 | $351.91 | 257.7M | $90.69B | $10.15B | $767.6M | $81.3B |